EMA Authorised: Aptivus (tipranavir) — Boehringer Ingelheim International GmbH

View source ↗

Summary

The European Medicines Agency authorised Aptivus (tipranavir) by Boehringer Ingelheim International GmbH for HIV infections (status: authorised as of 23 April 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Aptivus (tipranavir)

Snippet

Status: Authorised. Therapeutic area: HIV Infections. MAH: Boehringer Ingelheim International GmbH. Decision date: 23/04/2026